ANEMIA: Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital

• Sponsor: Hopital Nord Franche-Comte (Other)
• Overall Status: Completed
• CT.gov ID: NCT04812821
• Collaborator: (none)
• Enrollment: 1,177
• Location: 1
• Actual Duration (Months): 11.1
• Patients Per Site Per Month: 106.3

Study Details

Study Description

Brief Summary

Anemia is a common pregnancy condition that has multiple origins. Its frequency and severity seem to be increasing, despite the existing management recommendations and the awareness of health professionals. The objective of this study is to make a statement of this pathology within our establishment, to evaluate the proportion of patients presenting this pathology and to highlight possible risk factors.

Condition or Disease	Intervention/Treatment	Phase
Pregnancy Anemia	Other: questionnaire

Study Design

• Study Type: Observational
• Actual Enrollment: 1177 participants
• Observational Model: Other
• Time Perspective: Cross-Sectional
• Official Title: Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital
• Actual Study Start Date: Apr 12, 2021
• Actual Primary Completion Date: Oct 12, 2021
• Actual Study Completion Date: Mar 15, 2022

Outcome Measures

Primary Outcome Measures

1. Estimation of the proportion of patients presenting anemia during delivery [6 month]

   Percentage of patients with hemoglobin less than 10.5 g/dl at entry into the delivery room

Secondary Outcome Measures

1. Risk factors underlying anemia during delivery with a large questionnaire [6 month]

   Link between presence or absence of anemia and type of follow-up (gynecological or midwife, anemia during pregnancy and iron supplementation strategy and compliance), living conditions (geographical origin, socioeconomic situation, diet) and comorbidities

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• 18 years

• Delivery at Nord Franche-Comte Hospital

• Delivery ≥ 32 weeks of amenorrhea

• Informed patient and non-opposition of participation

Exclusion Criteria:

• Protected adults (Patients under guardianship, curatorship, safeguard of justice or under family authorization)

• Medical interruption of pregnancy

• Patients with fetal death in utero or neonatal death

• Minor patients

• Premature delivery before 32 weeks

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Hôpital Nord Franche-Comté	Trévenans		France	90400

Sponsors and Collaborators

• Hopital Nord Franche-Comte

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Hopital Nord Franche-Comte
• ClinicalTrials.gov Identifier: NCT04812821
• Other Study ID Numbers: 2019-02
• First Posted: Mar 24, 2021
• Last Update Posted: Mar 16, 2022
• Last Verified: Mar 1, 2021

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Anemia

Study Results

No Results Posted as of Mar 16, 2022